RIG-I like receptors in antiviral immunity and therapeutic applications.
about
A novel function of human Pumilio proteins in cytoplasmic sensing of viral infectionPPM1B negatively regulates antiviral response via dephosphorylating TBK1Inflammasomes and intestinal homeostasis: regulating and connecting infection, inflammation and the microbiotaRationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvantsRO 90-7501 enhances TLR3 and RLR agonist induced antiviral responseRIG-I-like receptors mediate innate antiviral response in mouse testis.Novel ATP-independent RNA annealing activity of the dengue virus NS3 helicaseMDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens.TLR-9 contributes to the antiviral innate immune sensing of rodent parvoviruses MVMp and H-1PV by normal human immune cells.Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells.Inflammasomes.Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune PotentiatorsCardif (MAVS) Regulates the Maturation of NK CellsMitogen-activated protein kinase-mediated licensing of interferon regulatory factor 3/7 reinforces the cell response to virusThe laboratory of genetics and physiology 2: emerging insights into the controversial functions of this RIG-I-like receptor.Functional Roles of Pattern Recognition Receptors That Recognize Virus Nucleic Acids in Human Adipose-Derived Mesenchymal Stem Cells.Deficiency of melanoma differentiation-associated protein 5 results in exacerbated chronic postviral lung inflammation.Systematic identification of small molecule adjuvants.Multi-level regulation of cellular recognition of viral dsRNA.The genetics of innate immunity sensors and human disease.Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)--an update.The role of lung dendritic cell subsets in immunity to respiratory viruses.Parts, assembly and operation of the RIG-I family of motors.The influence of viral RNA secondary structure on interactions with innate host cell defences.Synthetic agonists of NOD-like, RIG-I-like, and C-type lectin receptors for probing the inflammatory immune response.NLRC5 interacts with RIG-I to induce a robust antiviral response against influenza virus infection.The nucleocapsid proteins of mouse hepatitis virus and severe acute respiratory syndrome coronavirus share the same IFN-β antagonizing mechanism: attenuation of PACT-mediated RIG-I/ MDA5 activation.Pattern recognition receptor-initiated innate antiviral response in mouse adipose cells.Sublingual targeting of STING with 3'3'-cGAMP promotes systemic and mucosal immunity against anthrax toxins.Congenital Zika virus infection as a silent pathology with loss of neurogenic output in the fetal brain.A minimal RNA ligand for potent RIG-I activation in living mice.
P2860
Q24306232-CF1C91E9-8621-4481-9EE6-C034B79561C7Q24339402-2EC9A7C4-D82F-48BF-959C-7146ED8F9A3DQ27025039-21B812C2-194C-4827-922F-59322779BF3BQ27025822-D998C81C-3452-4258-A3F7-1DAFD904A0E8Q28484218-C1C07BB7-E9E6-41C3-A5FA-2894C1E3351FQ33633088-706B72EE-894C-48BB-99F7-224B742D04C7Q34257351-FB4FCC96-7973-449E-8807-365DE0744CD5Q34506918-367F9692-33D2-4283-9CB1-587CA2F8BE10Q34576048-2E68F419-39CE-4812-8125-429D587B2C9CQ34671862-7FE309EF-2A1C-4CF1-9EB5-FE30ED67DF83Q34931052-E593CB32-38AB-41C6-B050-001BE411C0E1Q35826747-40290362-B9EC-4391-B4B5-C9AAC3179B32Q36451854-31B2AA4C-DA8F-457D-9C65-42D52622E54DQ37428647-88B98D64-9E47-488A-9B6A-53ECA6B0DCFAQ37556622-FE1818B4-0375-4BC6-9FCA-E0AF7E429D9FQ37571601-54B849FD-AF5C-4419-A6D0-E05A3B02F7CCQ37688505-93105560-B165-4F99-98CE-41FE68859BF4Q38020881-00323E24-DB7C-49B5-9C04-3BC3EA2CA847Q38041927-580CD274-1510-4A2C-AE31-6E9EFAC74398Q38097500-DB985BB4-ED51-4BE5-ACC8-8B2D75C8023FQ38114627-BBDC4322-5520-4998-BC77-8E7185107268Q38129081-B2864EFB-75E6-427A-91AE-A27C7D9D271EQ38216121-D99697D5-E698-4A16-8855-6E20C5EF1134Q38256883-6766A125-1400-4296-847A-5A8D245B521FQ38646999-1D930C9C-5983-495E-8068-81535D4B7EA4Q38939803-D02BFE13-84F0-4E25-A1DB-7117686A24A2Q40168851-E1923BB2-BC3C-4D24-B21C-83CE98BB2C5DQ42259340-1356BA71-CBB2-45C9-AA67-DD2491B7B41BQ43170567-962AD5A1-8F9E-4248-99C1-D2A72F94C996Q48106134-FFDB5862-A04F-4475-AFE8-6DD2BFCEE6B7Q50335102-66CC29CF-A237-4783-8AE1-ECBC14AA1F34
P2860
RIG-I like receptors in antiviral immunity and therapeutic applications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
RIG-I like receptors in antiviral immunity and therapeutic applications.
@en
RIG-I like receptors in antiviral immunity and therapeutic applications.
@nl
type
label
RIG-I like receptors in antiviral immunity and therapeutic applications.
@en
RIG-I like receptors in antiviral immunity and therapeutic applications.
@nl
prefLabel
RIG-I like receptors in antiviral immunity and therapeutic applications.
@en
RIG-I like receptors in antiviral immunity and therapeutic applications.
@nl
P2860
P921
P356
P1433
P1476
RIG-I like receptors in antiviral immunity and therapeutic applications.
@en
P2093
Reneé C Ireton
P2860
P304
P356
10.3390/V3060906
P50
P5008
P577
2011-06-01T00:00:00Z
2011-06-23T00:00:00Z